设计和实施伊朗甲状腺癌国家质量登记:研究协议

Fateme Ziamanesh1, Mohammad Reza Mohajeri Tehrani1, Mahboobeh Hemmatabadi2

  • 1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

概括

这项研究在伊朗建立了甲状腺癌登记册,以追踪发病率,危险因素和结果. 目标是通过基于证据的干预措施改善甲状腺癌患者的护理和降低死亡率.